-
Great kickoff to
#LINC2020 in
with the master #Irad@lahinchman dominating Venous disease. Always an amazing meeting.@SIRspecialistspic.twitter.com/Wmz0dDTqIL – mjesto: Leipziger Messe
-
Really interesting that the signal was more pronounced in the US population data but not outside of US. Difference in patient followup pointed to as a source of differences.
#LINC2020 pic.twitter.com/20Sn5dJkod – mjesto: Leipziger Messe
-
#LINC2020 Japanese craftsmanship places much importance on precision,#IVUS is so integral to their#CLI success.pic.twitter.com/j195CmMR3v
-
Live
#LINC2020 Three negative DCB-BTK trials at 12 mos follow up: InPact Deep, Biolux II and now Lutonix BTK. Is the DCB-BTK space wide open or closing rapidly? https://twitter.com/EVToday/status/1222420258474156033 …
-
Live
#LINC2020 incredible results for an interwoven stent In the common femoral artery out to 24months and now a randomized trial against surgery!!@SIRspecialists@SIRRFSpic.twitter.com/2WD4RXhYwQ
-
Live
#LINC2020 welcome to Leipzig indeed. So glad to be a part of the premier global vascular meeting. Looks to be another great year!@SIRspecialists@SIRRFSpic.twitter.com/hjlMZDSwoo
-
Nothing like a morning live case from Italy!
#linc2020 pic.twitter.com/NaPf2xREgL
-
These ladies did an absolutely amazing job representing
#HMP and the#CardioVascularLearningNetwork while at#LINC2020. Blessed to work with such a talented & a hardworking team.@Colleen_Waters1 & Rebecca Kapurpic.twitter.com/Kui8jdL5da
-
Who else likes listening to symposia? My first one of the year at
#LINC2020 this week. It was a great meeting as always!#meded#cardioed#irad#venous#radialfirst#tavr#cardiotwitterpic.twitter.com/jFEdtcZ4vD
-
Initial results from EU and Canada post-market study of WavelinQ show 95% +/-3% functional patency at 6 months, with limited need for secondary procedures
#LINC2020 -
Interested in seeing a SIRT live case using Holmium-166 microspheres from
@UniJena? Come tomorrow to room 3 at 8:49#LINC2020#InterventionalOncologypic.twitter.com/00zZZC09IW
-
Thank you to chairmen and panel
@DrDeloose, Dr. G. Tepe, Dr. M. Lichtenberg,@Yanngoueffic,@miltoskrokidis, Prof. Dr. Ernst Weigang and attendees for a great live cases and discussion at#LINC2020. pic.twitter.com/TAQ8y2Kbqk
-
Opening day at
#LINC2020, where over 85% of live attendees believe there is an acceptable risk-benefit ratio for Paclitaxel use. pic.twitter.com/0tlv4gnQBp
-
Interview Prep
@PSchneiderMD collaborating with our managing editor of VER Ashlynne Merrifield at#LINC2020. Discussing the best approach to deliver the key take home points on Paclitaxel exposure and dosage of drug-coated balloons for the treatment of#PAD.#DCBpic.twitter.com/KdTz45kmLI
-
-
So true! Giving it some ‘umph’ today at
#LINC2020 pic.twitter.com/rK3zjcXeO5
-
this week at the restaurant so far: long work shifts, old white male guests, no tips at all
#LINC2020 -
Mind blowing talk about endovascular bypass! How would thick that would be possible?

#LINC2020@sirs_ksa@Interventional2@SIRspecialists@SIRRFS@SIR_ECS@pairsmedia@PairsWebpic.twitter.com/sDq0HLHTtI
-
1. Welcome to Europe. The first of many trips I'm sure! 2. You presented very well; didn't appear nervous and presented like it's second nature 3. Your are clearly strong in research -your presentation was excellent and I learnt some new things. Keep it up!
#LINC2020 pic.twitter.com/qaEQGrizW4
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.